A drop in demand for Illumina's array instruments, coupled with a market preference for lower complexity, and therefore lower priced, chips, caused the San Diego vendor's array revenues to decline by 3 percent in the third quarter, Illumina executives said this week.

At the same time, the company's management said it is "committed" to the array market and provided a positive forecast for the business, citing "substantial demand" in the quarter for its genotyping services and orders for its Infinium products that already have already exceeded total 2012 orders.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In a commentary at eLife, Brandeis University's Eve Marder calls on researchers to value and pursue truth.

Researchers have developed a way to quickly edit white blood cells, according to the New York Times.

In Science this week: rice gene enables plants to grow quickly in times of flooding, and more.

Education-linked genetic variants could also predict a small portion of a person's social mobility, Newsweek reports.